or Try an Advanced Search...

    Eye Diseases Stocks List

    Symbol Grade Name % Change
    AMPE F Ampio Pharmaceuticals, Inc. 0.00
    SCYX F SCYNEXIS, Inc. 0.00
    OCGN F Ocugen, Inc. 0.00
    SGHT F Sight Sciences, Inc 0.00
    OPT F Opthea Limited 0.00
    IMVT F Immunovant, Inc. 0.00
    EYPT D EyePoint Pharmaceuticals, Inc. 0.00
    OCUL D Ocular Therapeutix, Inc. 0.00
    OKYO C OKYO Pharma Limited 0.00
    IRIX C IRIDEX Corporation 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Devices
    Related Stock Lists: Eye Diabetic Retinopathy Dry Eye Disease Medicine Ophthalmology Biopharmaceutical Diabetic Macular Edema Glaucoma Inflammation Macular Edema Allergic Conjunctivitis Autoimmune Disease Biotechnology Blindness Cornea Diabetes Macular Degeneration Ophthalmic Ophthalmic Product Ophthalmic Products

    Related ETFs - A few ETFs which own one or more of the above listed Eye Diseases stocks.

    Symbol Grade Name Weight
    MVPA A Advisor Managed Portfolios Miller Value Partners Appreciation ETF 4.51
    SBIO C ALPS Medical Breakthroughs ETF 2.66
    XPH B SPDR S&P Pharmaceuticals ETF 2.38
    DEEP B Roundhill Acquirers Deep Value ETF 1.87
    PILL C Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 1.65
    View all Eye Diseases ETFs...
    Compare ETFs
    Compare MVPA to PILL Compare SBIO to DEEP Compare XPH to PILL

        Eye Diseases Stocks Recent News

        Date Stock Title
        Nov 21 IMVT Why Is Immunovant, Inc. (IMVT) Among the Worst Performing Biotech Stocks in 2024?
        Nov 20 OCGN Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
        Nov 19 SGHT Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference
        Nov 19 OCGN Ocugen reports positive data for OCU400, OCU410
        Nov 19 IRIX Iridex Comments on Changing Glaucoma Reimbursement Landscape
        Nov 19 OCGN Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
        Nov 18 SGHT Inside a $400 billion bet on the brain-computer interface revolution
        Nov 16 IRIX IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript
        Nov 15 OKYO MUSQ Global Music Industry ETF and OKYO Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Devices
        Related Stock Lists: Eye Medicine Dry Eye Disease Ophthalmology Diabetic Retinopathy Glaucoma Organ Systems Allergic Conjunctivitis Biopharmaceutical Biotechnology Blindness Chronic Disease Cornea Diabetes Diabetic Macular Edema Inflammation Macular Degeneration Macular Edema Ophthalmic Ophthalmic Product
        Eye Diseases

        Eye diseases are any medical condition that affects the eyes or vision. Common eye diseases include glaucoma, cataracts, age-related macular degeneration, diabetic retinopathy, and dry eye syndrome. These conditions can cause vision loss, pain, and other symptoms. Treatment for eye diseases may include medications, surgery, or lifestyle changes.

        Browse All Tags